《大行》里昂料百济神州(06160.HK)今年可实现经营扭亏 目标价大举升至209.8元

阿斯达克财经
28 Feb

里昂发表研报指,百济神州(06160.HK) (ONC.US)  自主研发产品BTK抑制剂销售表现强劲,超出市场预期,带动去年第四季收入按年增长78%,净亏损较上年同期收窄58.7%至1.52亿美元,则低于市场普遍预期。里昂将2025年视作百济神州实现经营盈亏平衡的里程碑年,根据去年业绩调整预测,并将目标价从156.8元大举上调至209.8元,重申“跑赢大市”评级。(gc/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-27 16:25。) (美股为即时串流报价; OTC市场股票除外,资料延迟最少15分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10